Insider Trading Alert - EAT, NAVB And INTC Traded By Insiders

Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

Brinker International (EAT) - FREE Research Report

Thomson Roger F, who is EVP, Ch. Dev. Officer at Brinker International, sold 7,500 shares at $46.50 on Nov. 4, 2015. Following this transaction, the EVP, Ch. Dev. Officer owned 100,823 shares meaning that the stake was reduced by 6.92% with the 7,500-share transaction.

The shares most recently traded at $45.47, down $1.03, or 2.27% since the insider transaction. Historical insider transactions for Brinker International go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 36,945
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 45,745

The average volume for Brinker International has been 1.4 million shares per day over the past 30 days. Brinker International has a market cap of $2.8 billion and is part of the services sector and leisure industry. Shares are down 21.88% year-to-date as of the close of trading on Wednesday.

Brinker International, Inc., together with its subsidiaries, engages in the ownership, development, operation, and franchise of casual dining restaurants worldwide. The stock currently has a dividend yield of 2.76%. The company has a P/E ratio of 15.0. Currently, there are 5 analysts who rate Brinker International a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EAT - FREE

TheStreet Quant Ratings rates Brinker International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Brinker International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Navidea Biopharmaceuticals (NAVB) - FREE Research Report

Larson Brent L, who is EVP, CFO, Treas & Sec'y at Navidea Biopharmaceuticals, sold 12,500 shares at $1.98 on Nov. 4, 2015. Following this transaction, the EVP, CFO, Treas & Sec'y owned 234,737 shares meaning that the stake was reduced by 5.06% with the 12,500-share transaction.

The shares most recently traded at $1.84, down $0.14, or 7.61% since the insider transaction. Historical insider transactions for Navidea Biopharmaceuticals go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 12,500
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 25,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 62,500

The average volume for Navidea Biopharmaceuticals has been 981,000 shares per day over the past 30 days. Navidea Biopharmaceuticals has a market cap of $293.9 million and is part of the health care sector and drugs industry. Shares are down 0.53% year-to-date as of the close of trading on Wednesday.

Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. Currently, there is 1 analyst who rates Navidea Biopharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NAVB - FREE

TheStreet Quant Ratings rates Navidea Biopharmaceuticals as a sell. The area that we feel has been the company's primary weakness has been its poor profit margins. Get the full Navidea Biopharmaceuticals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intel (INTC) - FREE Research Report

Krzanich Brian M, who is Ceo at Intel, sold 35,000 shares at $34.03 on Nov. 4, 2015. Following this transaction, the Ceo owned 357,426 shares meaning that the stake was reduced by 8.92% with the 35,000-share transaction.

The shares most recently traded at $33.94, down $0.09, or 0.25% since the insider transaction. Historical insider transactions for Intel go as follows:

  • 4-Week # shares sold: 240,860
  • 12-Week # shares sold: 314,462
  • 24-Week # shares sold: 376,825

The average volume for Intel has been 32.8 million shares per day over the past 30 days. Intel has a market cap of $161.9 billion and is part of the technology sector and electronics industry. Shares are down 5.9% year-to-date as of the close of trading on Wednesday.

Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments. The stock currently has a dividend yield of 2.8%. The company has a P/E ratio of 14.8. Currently, there are 19 analysts who rate Intel a buy, 3 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on INTC - FREE

TheStreet Quant Ratings rates Intel as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, notable return on equity, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Intel Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'